Dr. Prada finds it an honor to work with children, adults, and families with genetic diseases. His clinical work focuses on improving health for individuals with rare diseases by developing individualized and integrated care across specialties to promote their wellbeing. For 6 years, he co-led the RASopathies program at Cincinnati Children’s Hospital to develop a care-based model on genetic pathways. He has conducted randomized clinical trials of lysosomal storage disorders, neurofibromatosis type 1, RASopathies, mTORopathies, and several natural history studies of genetic disorders in partnership with family groups and foundations.
An author of over 60 publications, Dr. Prada has been the principal investigator on numerous federal and foundation grants, including grants from the Department of Defense (DoD), National Institute of Neurological Disorders and Stroke (NINDS), and the American College of Medical Genetics and Genomics (ACMG). He is the principal investigator for a large effort to develop novel biomarkers of tumor progression in neurofibromatosis type 1.
Dr. Prada served as the Associate Editor for the American Journal of Medical Genetics. He has an interest in international medicine and collaborates with the Cardiovascular Foundation of Colombia and Dominican Republic.
As an advocate in genetics, he is passionate to help build connections between families with rare genetic disorders to help develop foundations for future research and improve our understanding of disease and potential therapeutics. Educating the new generation of clinical and biochemical geneticists has been an area of focus. Dr. Prada has mentored numerous trainees who are now independent researchers and clinicians.
Dr. Prada joined the faculty at Cincinnati Children’s Hospital Medical Center in 2013. He became director of the RASopathies Program in 2016 and director of the Neurofibromatosis Program in 2020 at Cincinnati Children’s Hospital. In 2021, Dr. Prada joined Lurie Children’s and the Feinberg School of Medicine at Northwestern University as the Division Head of Genetics, Birth Defects and Metabolism.